Dark Forest Capital Management LP Enanta Pharmaceuticals Inc Transaction History

Dark Forest Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$38.82 - $54.59 $174,340 - $245,163	4,491 Added 49900.0%	4,500 $181,000
Q4 2022 Feb 13, 2023	BUY	$40.77 - $53.73 $366 - $483	9 New	9 $0
Q2 2022 Aug 15, 2022	SELL	$38.13 - $76.93 $1,525 - $3,077	-40 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$56.06 - $74.11 $2,242 - $2,964	40 New	40 $3,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $177M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.